Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

After 30 Years with Little or No Sleep, Skokie Man Turns to Breakthrough Inspire® Therapy, the First Implantable Device for Obstructive Sleep Apnea

Romeo Shoshoo, a Chicago ENT patient, suffered through daily episodes of falling asleep suddenly, even while walking


News provided by

PRWeb House E-Commerce

Mar 11, 2019, 05:55 ET

Share this article

Share toX

Share this article

Share toX

Inspire® Upper Airway Stimulation therapy utilizes a small generator, a sensing lead, and a stimulation lead.
Inspire® Upper Airway Stimulation therapy utilizes a small generator, a sensing lead, and a stimulation lead.

CHICAGO, Mar. 11, 2019 /PRNewswire-PRWeb/ -- Romeo Shoshoo, 61, of Skokie, missed every graduation of his three children. "Every morning, I would start walking then suddenly my eyes would completely shut; it was dangerous," said Shoshoo, whose transportation career abruptly ended 30 years ago following the onset of obstructive sleep apnea.

During the past year, Shoshoo, a Chicago ENT patient, has restored his quality of sleep, averaging more than seven hours a night thanks to Inspire® Upper Airway Stimulation therapy, a relatively new treatment option for obstructive sleep apnea.

“Inspire is the best treatment option we’ve ever had for treating obstructive sleep apnea.” – Michael Friedman, MD, founder and medical director of Chicago ENT

Post this

"Before Inspire, my wife Susan and I spent 30 years sleeping in separate bedrooms due to my horrendous snoring," explained Shoshoo. "CPAP was too uncomfortable and no matter how cold it was in our home, I would sweat heavily." According to studies, roughly half of all patients that begin Continuous Positive Airway Pressure (CPAP) therapy eventually stop using the device as prescribed.

Sleep deprivation and a lack of oxygen during sleep can cause short- and long-term health risks, including heart disease, heart attack, stroke, depression, and memory loss.

  • National Sleep Awareness Week is March 10-16, 2019
  • 40% of Americans sleep less than seven hours a night
  • 5-20% of adults are affected by obstructive sleep apnea, per sleep test results

One goal of National Sleep Awareness Week is to encourage those suffering from obstructive sleep apnea to share their experiences with others who may be unaware of the various treatments.

"Inspire is the best treatment option we've ever had for treating obstructive sleep apnea," said Michael Friedman, MD, founder and medical director of Chicago ENT, one of only a few otolaryngology groups in Illinois to provide the FDA-approved Inspire therapy. Chicago ENT is an advanced center for sleep specialty care with four locations across Chicagoland.                                                                            

Minimally invasive Inspire therapy is the first implantable device that treats obstructive sleep apnea. It is intended for people who are unable to use or get consistent benefits from CPAP. During sleep, Inspire monitors every breath. Based on the person's unique breathing patterns, the system delivers mild stimulation to the hypoglossal nerve, which controls the movement of the tongue and other key airway muscles. By stimulating these muscles, the airway remains open during sleep. The system essentially keeps the tongue "awake" while the patient sleeps.

"We've come a long way with obstructive sleep apnea treatments," added Dr. Friedman. "The concept
of creating space in the throat has been really challenging. And fortunately, Inspire therapy has dramatically changed peoples' lives."

"I'm thrilled with the results I've had with Inspire," said Michael Diaz, 52, of Mount Prospect. "I tried everything, CPAP, two dental appliances. Nothing worked for me. Dr. Friedman completely changed my life with Inspire. I'm averaging close to eight hours of sleep, and I'm getting deep sleep and dreams too, which I've never experienced in my adult life."

According to Inspire Medical Systems, the manufacturer of Inspire therapy, studies show patients using the therapy experience significant reductions in obstructive sleep apnea events (a 78% reduction in sleep apnea events per hour), increased daytime activity levels, and reduced daytime sleepiness.

Inspire therapy utilizes a small generator, a sensing lead, and a stimulation lead. Treatment is controlled by a small handheld sleep remote. The remote turns the Inspire therapy on before bed and stimulation is turned off when the person wakes up. The remote can increase or decrease the stimulation strength.

Inspire therapy is for an obstructive sleep apnea patient who:

  • has moderate to severe obstructive sleep apnea
  • is unable to use or get consistent benefits from CPAP
  • is not significantly overweight
  • is over the age of 22

Shoshoo's wife, Susan, is much happier, "I got my husband back! Imagine 30 years in separate bedrooms. I'm so happy for him, for all of us." Learn more about Inspire sleep apnea therapy here.

Inspire Community Education Events – registration is limited:

SKOKIE:
Wednesday, March 13, 2019
Shallots Bistro
7016 Carpenter Rd., Skokie, IL 60077
6:30-8:00 p.m. | Information and registration

CHICAGO:
Thursday, April 4, 2019
Advocate Illinois Masonic Medical Center, Olson Auditorium
836 W. Wellington Ave., Chicago, IL 60657
6:30-8:00 p.m. | Information and registration

ABOUT CHICAGO ENT:
Since 1977, Chicago ENT (http://www.chicagoent.com) is focused on the mission of bringing full-spectrum ENT care to our patients, through integrated, comprehensive care for sleep apnea, thyroid and parathyroid disease, and all diseases of the ear, nose, and throat. Founder and medical director Michael Friedman, MD, is a world-renowned otolaryngologist and sleep specialist who has authored more than 200 academic articles and textbook chapters. Chicago ENT specialists see patients at four locations in the Chicago area: Lincoln Park, Bucktown, Chicago North, and Skokie.

CONTACT:
For additional information, contact Dave Bloom of Bloom PR at (561) 866-3392 or dave.bloom(at)ournewsroom(dot)com.

SOURCE PRWeb House E-Commerce

Related Links

https://chicagoent.com

Modal title

Michael Friedman, MD, is Chicago ENT's founder and medical director. The world-renowned otolaryngologist and sleep specialist has authored over 200 academic articles and textbook chapters.
Michael Friedman, MD, is Chicago ENT's founder and medical director. The world-renowned otolaryngologist and sleep specialist has authored over 200 academic articles and textbook chapters.
Chicago ENT is one of only a few otolaryngology groups in Illinois to provide FDA-approved Inspire® therapy. Chicago ENT has four locations in greater Chicago.
Chicago ENT is one of only a few otolaryngology groups in Illinois to provide FDA-approved Inspire® therapy. Chicago ENT has four locations in greater Chicago.
Minimally invasive Inspire® therapy is the first implantable device that treats obstructive sleep apnea. It is intended for people who are unable to use or get consistent benefits from CPAP.
Minimally invasive Inspire® therapy is the first implantable device that treats obstructive sleep apnea. It is intended for people who are unable to use or get consistent benefits from CPAP.
Michael Friedman, MD, is Chicago ENT's founder and medical director. The world-renowned otolaryngologist and sleep specialist has authored over 200 academic articles and textbook chapters. Chicago ENT is one of only a few otolaryngology groups in Illinois to provide FDA-approved Inspire® therapy. Chicago ENT has four locations in greater Chicago. Minimally invasive Inspire® therapy is the first implantable device that treats obstructive sleep apnea. It is intended for people who are unable to use or get consistent benefits from CPAP.

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.